This training program is designed to provide pre- and postdoctoral candidates with the individual intellectual and technical skills required to become outstanding academic scientists in the field of Immunology.
The aim i s to utilize the growth of Immunology and the expansion of its faculty at Mount Sinai as a resource to create a fertile environment for the development of graduate students and postdoctoral fellows. Each trainee is exposed not only to direct laboratory research but also has the opportunity (actually required) to participate in the educational programs focused on Immunology established here at Mount Sinai. For physician scientists there will be ample opportunity to immerse themselves in translational research programs relating to cytokine biology, cancer, neurobiology, HIV related disorders, food allergy, mucosal immunity, autoimmunity and primary immune deficiency. There is formal course work, seminar series, journal clubs, a yearly retreat, and work in progress meetings (attended by the entire Immunology faculty and trainees). A single faculty member acts as a preceptor for a given fellow or graduate student supervising his/her laboratory work, orchestrating an appropriate training program (e.g. course work), and providing an environment that will help foster maturation towards an independent career in Immunology research. The program has successfully recruited outstanding trainees from a number of prestigious institutions who have been attracted to Mount Sinai because of the enormous growth in the basic sciences, excellence in research, interactive faculty, a protective and nurturing mentoring environment and a clear commitment to student and postdoctoral fellowship training.
This training program is designed to provide pre- and postdoctoral candidates with the individual intellectual and technical skills required to become outstanding academic scientists in the field of Immunology. The aim is to utilize the growth of Immunology and the expansion of its faculty at Mount Sinai as a resource to create a fertile environment for the development of graduate students and postdoctoral fellows.
|Saxena, Mansi; Balan, Sreekumar; Roudko, Vladimir et al. (2018) Towards superior dendritic-cell vaccines for cancer therapy. Nat Biomed Eng 2:341-346|
|Saxena, Mansi; Bhardwaj, Nina (2018) Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment. Trends Cancer 4:119-137|
|Agudo, Judith; Park, Eun Sook; Rose, Samuel A et al. (2018) Quiescent Tissue Stem Cells Evade Immune Surveillance. Immunity 48:271-285.e5|
|Audenet, François; Farkas, Adam M; Anastos, Harry et al. (2018) Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer. World J Urol 36:1741-1748|
|Ang, Rosalind L; Ting, Adrian T (2018) Detection of RIPK1 in the FADD-Containing Death Inducing Signaling Complex (DISC) During Necroptosis. Methods Mol Biol 1857:101-107|
|Li, Cheuk Wun; Osman, Roman; Menconi, Francesca et al. (2017) Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes. J Autoimmun 76:1-9|
|Li, Cheuk Wun; Menconi, Francesca; Osman, Roman et al. (2016) Identifying a Small Molecule Blocking Antigen Presentation in Autoimmune Thyroiditis. J Biol Chem 291:4079-90|
|Mathern, Douglas R; Heeger, Peter S (2015) Molecules Great and Small: The Complement System. Clin J Am Soc Nephrol 10:1636-50|
|Campisi, L; Cummings, R J; Blander, J Magarian (2014) Death-defining immune responses after apoptosis. Am J Transplant 14:1488-98|
|Swartz, Talia H; Esposito, Anthony M; Durham, Natasha D et al. (2014) P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection. J Virol 88:11504-15|
Showing the most recent 10 out of 19 publications